ArticleClinical and translational science2022

Pharmacokinetics of asciminib in the presence of CYP3A or P-gp inhibitors, CYP3A inducers, and acid-reducing agents.

Matthias Hoch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.